Login / Signup

Treatment with Myo-Inositol Does Not Improve the Clinical Features in All PCOS Phenotypes.

Vittorio UnferMichele RussoCesare AragonaGabriele BilottaMario Montanino OlivaMariano Bizzarri
Published in: Biomedicines (2023)
Subjects selected for the study exhibited a differential response to myo-Ins therapy according to their PCOS phenotypes. The data suggest that the same treatment might not equally improve the parameters of the PCOS condition in each sub-group of patients. It is crucial to distinguish the various phenotypes to properly select the therapeutical approach.
Keyphrases
  • polycystic ovary syndrome
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • machine learning
  • peritoneal dialysis
  • adipose tissue
  • replacement therapy
  • deep learning
  • patient reported